Profile
| Metric | Value |
|---|---|
| Full Name | Evoke Pharma, Inc. |
| Ticker | NASDAQ: EVOK |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | evokepharma.com |
| Employees | 3 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $11.00 | |
| Price, 1D Change | - | |
| $19M | ||
| - | ||
| - | ||
| 0.37 | ||
| $10M | ||
| Revenue, 1Y Change | +97.84% | |
| -$2.81 | ||
| EPS, 1Y Change | +89.96% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:12 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.81 | ||
| EPS Estimate | N/A | -$1.88 |
| EPS Est. Change | N/A | +33.08% |
| $10.25M | ||
| Revenue Estimate | N/A | $15.97M |
| Revenue Est. Change | N/A | +55.84% |
| Current Price | $11.00 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.23 | -$27.97 | -1,154.29% | |
| -$3.98 | -$2.81 | +29.41% | |
| -$1.88 | N/A | +33.08% | |
| $0.68 | N/A | +124.20% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $5.14M | $5.18M | +0.79% | |
| $10.02M | $10.25M | +2.25% | |
| $15.97M | N/A | +55.84% | |
| $25.24M | N/A | +146.21% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $11.00 | |
| $5.04 | ||
| SMA 200 vs Price | -54.18% | |
| $8.52 | ||
| SMA 50 vs Price | -22.58% | |
| 0.37 | ||
| $0.12 | ||
| 85.01 | ||
| 2.03% | ||
| 228.87% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $10.25M | ||
| -$2.81 | ||
| $9.89M | ||
| 96.52% | ||
| -$5.20M | ||
| -50.77% | ||
| -$5.35M | ||
| -52.22% | ||
| -$4.85M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.73 | ||
| 1.66 | ||
| 1.62 | ||
| - | ||
| 3 | ||
| -9.07 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 1.31 | ||
| 5.64 | ||
| -2.40 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $7.04M | ||
| $13.60M | ||
| $17.52M | ||
| $17.24M | ||
| $10.48M | ||
| $10.38M | ||
| $5.16M | ||
| $5.06M | ||
| $2.34M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $15.45M | ||
| $15.10M | ||
| $356.50K | ||
| $15.08M | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$5.46M | ||
| $0.00 | ||
| $14.32M | ||
| $0.00 | ||
| -$5.46M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| H.C. Wainwright | → | |
| Seaport Global | ||
| Laidlaw & Co. | → | |
| Rodman & Renshaw | → | |
| Noble Financial | → | |
| Rodman & Renshaw | → | |
| Brean Capital | → | |
| Northland Securities | ||
| Ascendiant Capital |
Analyst sentiment
Institutional ownership
Screeners with EVOK
Data Sources & References
- EVOK Official Website www.evokepharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1403708/000095017025038712/0000950170-25-038712-index.htm
- EVOK Profile on Yahoo Finance finance.yahoo.com/quote/EVOK
- EVOK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/evok
FAQ
What is the ticker symbol for Evoke Pharma, Inc.?
The ticker symbol for Evoke Pharma, Inc. is NASDAQ:EVOK
Does Evoke Pharma, Inc. pay dividends?
No, Evoke Pharma, Inc. does not pay dividends
What sector is Evoke Pharma, Inc. in?
Evoke Pharma, Inc. is in the Healthcare sector
What industry is Evoke Pharma, Inc. in?
Evoke Pharma, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Evoke Pharma, Inc. based in?
Evoke Pharma, Inc. is headquartered in United States
When did Evoke Pharma, Inc. go public?
Evoke Pharma, Inc. initial public offering (IPO) was on September 25, 2013
Is Evoke Pharma, Inc. in the S&P 500?
No, Evoke Pharma, Inc. is not included in the S&P 500 index
Is Evoke Pharma, Inc. in the NASDAQ 100?
No, Evoke Pharma, Inc. is not included in the NASDAQ 100 index
Is Evoke Pharma, Inc. in the Dow Jones?
No, Evoke Pharma, Inc. is not included in the Dow Jones index
When was Evoke Pharma, Inc. last earnings report?
Evoke Pharma, Inc.'s most recent earnings report was on November 7, 2024
When does Evoke Pharma, Inc. report earnings?
The date for Evoke Pharma, Inc.'s next earnings report has not been announced yet